Nirsevimab Clinical Trials
7 recruitingBiologic
Early Phase 11Phase 31
Showing 1–7 of 7 trials
Recruiting
Phase 3
Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination
RSV Immunization
Centre Hospitalier Annecy Genevois1,000 enrolled1 locationNCT07232706
Recruiting
A Post-marketing Surveillance Study of Beyfortus (Nirsevimab) in Republic of Korea
Respiratory syncytial virus
Sanofi3,000 enrolled1 locationNCT07200206
Recruiting
Early Phase 1
A Clinical Trial of SIBP-A16 Injection in Healthy Adults
Respiratory Syncytial Virus (RSV)
Shanghai Institute Of Biological Products140 enrolled1 locationNCT07106918
Recruiting
Real-World Effectiveness of Perinatal RSV Immunoprophylaxis
RSV Infection
Yale University3,750 enrolled1 locationNCT06172660
Recruiting
Evaluation of the Effect of Nirsevimab on Hospitalizations Due to RSV Infection in Infants Under One Year of Age.
Respiratory Synctial Virus Infections
Meyer Children's Hospital IRCCS138 enrolled8 locationsNCT06856967
Recruiting
Effectiveness And Impact Of Nirsevimab In Chile (NIRSE-CL)
RSV
Instituto Sistemas Complejos de Ingeniería160,000 enrolled1 locationNCT06511687
Recruiting
Evaluation of the Effectiveness and Impact of Nirsevimab Administered as Routine Immunization
RSV Infection
Federico Martinón Torres42,000 enrolled1 locationNCT06180993